SMAD5 and nasopharyngeal carcinoma: Here, we hypothesized that miR-384 could suppress NPC progression through Smad5 inhibition, and gain- and loss-of-functions of miR-384 and Smad5 were performed in both cell and animal models to validate this hypothesis.